The drug did not cause any adverse effects on patients. The same drug will be sold to a subsidized amount of Rs. 84,000. Minister Senaratne also said that two more cancer drugs will be registered after processing the applications. The registration will be done by the National Medicines Regulatory Authority (NMRA), the Minister said.

The Russian drug which was brought down to Sri Lanka was rejected by the Sri Lanka College of Oncologists (SLCO) in the first quarter of last year fearing of possible complications that can be developed in patients who use it as it was not commonly used around the world